Monitoring Abstinence Martin H. Plawecki MD, PhD Indiana University School of Medicine Department of Psychiatry Alcohol Medical Scholars Program.

Slides:



Advertisements
Similar presentations
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Advertisements

Presenters: Promoting Regulatory Excellence Use of Substance Abuse Testing in Licensure Actions Donna R. Smith, PhD FirstLab, Inc.
Drugs For Treating Drug Addiction Barry Zevin MD Tom Waddell Health Center San Francisco Department of Public Health Homeless Programs Board Certified.
Greg L. Jones, MD Medical Director Kentucky Physicians Health Foundation How to Recognize Drug Abuse and Dependence in Patients.
Maintenance Phase Judith Martin, MD Medical Director, The 14 th Street Clinic, Oakland.
Copyright Alcohol Medical Scholars Program A Clinical Guide To Assessing Alcohol Use And Problems Andrea DiMartini M.D. University of Pittsburgh.
Copyright Alcohol Medical Scholars Program1 Substance Use Disorders: Does Treatment Work? Christina M. Delos Reyes, MD Department of Psychiatry CWRU School.
Swinomish Wellness Program
Drug Schedules. Goal: to organize the control of drugs under 5 classifications (schedules of controlled substances) Potential for abuse Accepted medical.
Module 4: Interaction of. Objectives To be aware of the possible reasons why dual diagnosis occurs To be aware of the specific effects of substances on.
Monitored Abstinence Martin H. Plawecki MD, PhD Indiana University School of Medicine Department of Psychiatry Alcohol Medical Scholars Program.
Copyright Alcohol Medical Scholars Program 1 Opioid Agonist Treatment: “Trading one substance for another?” Joseph Sakai, M.D.
HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program.
for the PRITE is proud to present And Now Here Is The Host... Insert Name Here.
Methadone in Opioid Addiction David Kan, M.D. University of California San Francisco VA Medical Center San Francisco.
Substance Abuse Issues in Health Professionals Shannon V Chavez, MD Chair, UCSD Physician Well-Being Committee Director, UCSD Health Professional Program.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
Forensic Drug Analysis ON-SITE DRUG TESTS SCREENING TESTS
Copyright Alcohol Medical Scholars Program1 Screening and Brief Interventions for Heavy Drinking Laura Jean Bierut, MD Alcohol Medical Scholars.
Practicalities of Conducting Biological Assessments for Drug Use Kenzie L. Preston, Ph.D. Chief, Clinical Pharmacology and Therapeutics Research Branch.
Copyright Alcohol Medical Scholars Program1 The Relationships Between Alcohol Use Disorders and Nicotine Dependence Margaret Rukstalis, M.D. University.
What is a Drug??? A drug is any chemical substance that changes the physical, mental or emotional state of the body. A drug is any chemical substance.
DOUGHNUTSDOUGHNUTS. Opioid Agonist Therapy The Skinny on Methadone et al.
Treatment 101 Substance Abuse Basics West Coast Consulting Wanda King
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module III – Buprenorphine 101.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
Healthcare Reform The “Affordable Care Act” How Will It Affect Substance Abuse Care?
Good Prescribing to support Criminal Justice Interventions
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
Types of Drug Tests 1.Urine drug screen. Types of Drug Tests 2.Hair drug screen.
DRUGS OF ABUSE Reynaldo J. Lesaca, M.D. Reynaldo J. Lesaca, M.D.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
Raymond F. Anton, MD for The COMBINE Study Research Group
Legal Applications for Drug and Alcohol Testing Kelly R. Broome ARCpoint Labs
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Module 1 General introduction to substitution treatment.
Opiates and Pain PAIN Spinal Cord Substance P BRAIN Opiates.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Don Teater MD Medical Advisor National Safety Council Itasca, IL Medical Provider Behavioral Health Group Asheville, NC Medical Provider Meridian Behavioral.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Substance Abuse Spring Substance-Related Disorders Substance abuse Substance dependence –Tolerance –Withdrawal Substance intoxication 2 Define substance.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
1 SAMPLE ALTERNATIVES URINE BLOOD BREATH SALIVA HAIR SWEAT.
MRCPsych addiction psychiatry seminar series Policy, guidance and legal framework of addiction treatment Classification of substance use disorders Assessment.
How To Pass A Hair Drug Test. What is a Hair Drug Test? As its name connotes, this kind of drug testing uses hair follicles to establish and verify persistent.
Tobacco. Nicotine is a stimulant drug found in tobacco products, including cigarettes, clove cigarettes, cigars, chewing tobacco, pipe tobacco, and snuff.
The most common form of drug test is the urine test, likely due to its inexpensiveness. Urine testing detects past drug use, not real-time. Urine tests.
NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.
Brief Intervention. Brief Intervention has a number of different definitions but usually encompasses: –assessment –provision of education, support and.
STATE BAR OF TEXAS ADVANCED FAMILY COURSE: 2015 AUGUST 3-6, 2015 SAN ANTONIO, TEXAS.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
screening, brief intervention, and referral to treatment
screening, brief intervention and referral to treatment
New York State Treatment System
Medication-Assisted Therapy at Coleman Profession Services
Heroin.
Employment Drug Testing
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Opioid Prescribing & Monitoring
Controlled substance compliance
Assessing Opioid Use Disorder, part 1
Workplace Drug and Alcohol Testing
Understanding and Using ASAM Criteria
Stephen Maisto, Professor of Psychology, College of Arts & Sciences, SU “Alcohol and other Substance Use: Treatment, Determinants, and Co-Morbidities”
ADDICTION
The Judicial Branch’s Response to the Opioid Crisis
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
PSYCHOPATHOLOGY OF CHILDREN AND FAMILY
Presentation transcript:

Monitoring Abstinence Martin H. Plawecki MD, PhD Indiana University School of Medicine Department of Psychiatry Alcohol Medical Scholars Program

Introduction Many diseases: chronic, relapsing, remitting Controlled, not cured Examples Type I diabetes: 30-50% relapse rate High blood pressure: 50-70% relapse rate Substance use disorders (SUDs): 40-60% relapse rate © Alcohol Medical Scholars Program2

Goals of SUD Treatment Harm reduction Abstinence Abstinence monitoring has a role in both © Alcohol Medical Scholars Program3

This Lecture Covers Definition/course of Substance Use Disorders (SUDs) Goals of monitoring abstinence and detection Abstinence monitoring substance examples Efficacy of monitored abstinence © Alcohol Medical Scholars Program4

This Lecture Covers Definition/course of Substance Use Disorders (SUDs) Definition/course of Substance Use Disorders (SUDs) Goals of monitoring abstinence and detection Abstinence monitoring substance examples Efficacy of monitored abstinence © Alcohol Medical Scholars Program5

Substance Use Disorder In Same Year, ≥2 of: Tolerance Withdrawal Use longer/more Unable to ↓ Lots time use ↓ Activities Use despite probs Craving © Alcohol Medical Scholars Program6 Failed roles Hazardous use Social problems

Substance Use Disorder II © Alcohol Medical Scholars Program7 Abstinence Controlled Use Problems

This Lecture Covers Definition/course of Substance Use Disorders (SUDs) Goals of monitoring abstinence and detection Goals of monitoring abstinence and detection Abstinence monitoring substance examples Efficacy of monitored abstinence © Alcohol Medical Scholars Program8

Goals of Monitoring Abstinence Improve treatment outcomes by: Improving treatment compliance Verifying prescribed substance usage Detecting problematic usage Safety Objective is NOT punitive © Alcohol Medical Scholars Program9

Detection When and how are dependent on what Both are determined by drug Absorption – how and how much drug enters Distribution – where drug goes in body Metabolism – what body does to drug Elimination – how drug is eliminated © Alcohol Medical Scholars Program10

Detection II Strategies Detect chemical itself Detect metabolites Detect secondary effects Detection can be chemical or electrical within Blood Breath Sweat Hair Urine © Alcohol Medical Scholars Program11

This Lecture Covers Definition/course of Substance Use Disorders (SUDs) Goals of monitoring abstinence and detection Abstinence monitoring substance examples Abstinence monitoring substance examples Efficacy of monitored abstinence © Alcohol Medical Scholars Program12

Monitoring Abstinence - Breath Advantages Easy, non-invasive Cost – reusable device Disadvantages Must be done properly Possibly non-specific © Alcohol Medical Scholars Program13 Draeger Alcotest

Monitoring Breath - Alcohol Alcohol is water soluble & appears in breath Electrochemical detection (burns alcohol) Deep breath is proportional to blood level Detects low [alcohol] (1 drink in past hour) © Alcohol Medical Scholars Program14

Monitoring Breath - Nicotine CO from burning tobacco in breath Electrochemical detection (burns CO) Detected up to 2 dys; “smoker” sensitivity < 10 hrs © Alcohol Medical Scholars Program15

Monitoring Abstinence - Urine Advantages Easy to obtain/non-invasive Detection via specific antibodies Common and inexpensive Disadvantages Positive test → expensive replication Replication takes weeks to get results Specific drugs detected for different time lengths Cheating © Alcohol Medical Scholars Program16

Monitoring Abstinence – Urine II Urine drug screen Specific antibody screening for substances/byproducts Many substances can be screened in a single test © Alcohol Medical Scholars Program17

Times for Useful Urine Monitoring Opioids – 1-3 days Cannabinoids Single use – 3 days Daily – days Heavy – >30 days Amphetamines – 2 days Detection Times Cocaine – 2-4 days PCP – 8 days Alcohol – ¼ - ½ day Sedatives Short-acting – 3 days Long-acting – 30 days © Alcohol Medical Scholars Program18

A Problem With Urine Monitoring Cheating Adulterants - substances added to urine sample Dilution - intentional fluid over-ingestion Substitution - use of another’s, old, or synthetic urine False attribution - claimed use of one to hide another © Alcohol Medical Scholars Program19

Monitoring Abstinence - Blood Advantages Highly specific → confirm other tests Difficult to cheat, low false positives Direct and indirect measurements possible Disadvantages Invasive – requires a blood draw Expensive – includes testing and procedure fees © Alcohol Medical Scholars Program20

Monitoring Blood - Alcohol Alcohol: Blood Alcohol Concentration Direct detection of alcohol Limited to recent consumption only Alcohol: Carbohydrate deficient transferrin (CDT) Indirect marker - ↑ alcohol > 2 wks → ↑ CDT Timing: abstinence → ↓ CDT in 2-5 weeks © Alcohol Medical Scholars Program21

Monitoring Blood - Cannabis Direct detection of cannabinoids Acute use: peaks in min, ↓ 0 for 1 day Chronic: detectable up to 30 days © Alcohol Medical Scholars Program22

Monitoring Abstinence - Sweat Advantages Largely non-invasive Relatively tamper resistant Can be done chemically and electronically Wide variety of substances can be detected Disadvantages Positive test → expensive replication Difficult to quantify Unclear effects of exercise → ↑sweat © Alcohol Medical Scholars Program23

Monitoring Sweat - Chemical Swab collection Primarily to verify intoxication Detects recent usage only (<24 hours) Patch collection Detection over longer time window (1-2 wks) May provide a cumulative measure of the interval Possible for drugs to be re-absorbed © Alcohol Medical Scholars Program24 PharmaChem Patch

Monitoring Sweat - Electronic Advantages Continuous monitoring Data can be monitored remotely Disadvantages Intrusive and highly visible Expensive Optimized for forensics © Alcohol Medical Scholars Program25

Sweat Monitoring - Alcohol Alcohol → sweat Samples every 30 minutes Automatic alerts Tamper Resistant Cost Lease: $6-8/day lease Purchase: $1,400-1,800 + $5/day © Alcohol Medical Scholars Program26

Monitoring Abstinence - Other Hair Advantages Chemical detection Long-term use patterns Non-invasive Limited cheating Disadvantages Limited substances No acute intoxication 1 week until detection + → $$$ confirmation Saliva Advantages Chemical detection Acute intoxication Non-invasive Limited Cheating Sensitive Disadvantages Short detection time + → $$$ confirmation © Alcohol Medical Scholars Program27

Monitoring Other - Examples Hair Drug → follicles → hair ~100 hairs cut by scalp Detects Cocaine Amphetamines Opiates PCP THC Ecstacy Saliva Drug → blood → saliva Pad placed in cheek Detects Cocaine Amphetamines Opiates PCP THC Sedatives © Alcohol Medical Scholars Program28

This Lecture Covers Definition/course of Substance Use Disorders (SUDs) Goals of monitoring abstinence and detection Abstinence monitoring substance examples Efficacy of monitored abstinence Efficacy of monitored abstinence © Alcohol Medical Scholars Program29

Methadone Maintenance Goal: ↓ health risk, ↓ crime, ↑ family/job Replacement: methadone vs heroin Lasts >24hours → 1x/day dosing Allows work; avoids withdrawal and prevent “high” Cheaper & from clinic → ↓ risky acts, ↓crimes Highly structured and federally regulated Administer methadone daily, usually at clinic Monitor for abstinence – urine drug screens Requires counselling © Alcohol Medical Scholars Program30

Methadone Maintenance Efficacy 3x ↑ Remain in Rx vs no opiate replacement 2/3x ↓ Positive opioid hair/urine samples 2 ½x ↓ Crime involvement © Alcohol Medical Scholars Program31

Chronic Pain Management Goal: control pain, minimize substance misuse Adherence monitoring and risk minimization Explicit behavior agreements Estimate risk Use difficult-to-misuse medications Rx drug monitoring programs Urine drug screens Success → continue in program Failure → lose access to prescription opioids © Alcohol Medical Scholars Program32

Chronic Pain Management Efficacy Urine drug testing → ↓ illicit drug usage ↑ Urine drug tests → ↑ prescription adherence ↓ non-Rx medications © Alcohol Medical Scholars Program33

Court Mandated Rx Goal: ↓ drug use → ↓ crime Links highly structured Rx to legal system Residential and outpatient treatment Random urine drug screens Routine judicial interaction and progress monitoring Success → avoid jail Failure→ ↑ Monitoring frequency/intensity ↑ Punishment up to jail © Alcohol Medical Scholars Program34

Court Mandated Rx Efficacy 12% ↓ Criminal relapse No clear effect on SUD outcomes Difficult to quantify Highly variable population Different Rx approaches/referral networks © Alcohol Medical Scholars Program35

Physician Health Programs Goal: ↓ patient harm Links highly structured Rx to medical license Residential and outpatient treatment Random urine drug screens +/- Random office visit ≥5 Yr follow-up Success → practice medicine, keep job Failure → Treatment, ↑monitoring frequency/intensity Referral to medical licensing board © Alcohol Medical Scholars Program36

Soberlink Blue Device System © Alcohol Medical Scholars Program37

Physicians Health Programs Efficacy Only ~20% w/ +UDS at any time during 5 yrs 70-80% Physicians still licensed/employed at 5 yrs © Alcohol Medical Scholars Program38

Summary SUDs are chronic relapsing/remitting conditions Abstinence monitoring is therapeutic Monitoring can be chemical and electronic Monitored abstinence → better outcomes © Alcohol Medical Scholars Program39

Questions © Alcohol Medical Scholars Program40